Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, NC 27599-7365, USA.
Biochem Biophys Res Commun. 2011 Jan 7;404(1):370-5. doi: 10.1016/j.bbrc.2010.11.125. Epub 2010 Dec 9.
Equilibrative nucleoside transporters (ENTs) are facilitative transporters broadly selective for pyrimidine and purine nucleosides and are essential for the modulation of nucleoside concentration and nucleoside analog availability. Resistance to nucleoside-derived drugs strongly correlates with a deficiency of ENT1 expression in several tumor cells. Thus, it is crucial to understand the mechanisms by which this transporter is modulated. Using a mouse myeloid leukemic cell line as a model, we investigated whether stress-activated kinases regulate ENT1 expression and function. JNK activation, but not p38 MAPK results in rapid loss of mENT1 function, mRNA expression and promoter activity. c-Jun but not the mutant c-Jun Ser63/73Ala, decreased mENT1 promoter activity. Moreover cJun bound to an AP-1 site identified at -1196 of the promoter, suggesting a specific role for this transcription factor in mENT1 regulation. We propose that activation of JNK-cJun pathway negatively regulates mENT1 and suggest that this mechanism might contribute to the development of nucleoside analog-derived drug resistance.
平衡核苷转运体(ENTs)是一种广泛选择性嘧啶和嘌呤核苷的易化转运体,对于调节核苷浓度和核苷类似物的可用性至关重要。几种肿瘤细胞中 ENT1 表达的缺乏与对核苷衍生药物的耐药性强烈相关。因此,了解这种转运体被调节的机制至关重要。我们使用小鼠髓样白血病细胞系作为模型,研究了应激激活的激酶是否调节 ENT1 的表达和功能。JNK 的激活,而不是 p38 MAPK,导致 mENT1 功能、mRNA 表达和启动子活性的快速丧失。c-Jun 但不是突变的 c-Jun Ser63/73Ala,降低了 mENT1 启动子活性。此外,cJun 与启动子-1196 处鉴定的 AP-1 位点结合,表明该转录因子在 mENT1 调节中具有特定作用。我们提出 JNK-cJun 途径的激活负调节 mENT1,并表明这种机制可能有助于核苷类似物衍生药物耐药性的发展。